Abstract
For more than two decades prior to the discovery of the hepatitis C virus (HCV), posttransfusion non-A, non-B (NANB) hepatitis was thought to have a viral etiology. In 1989, the virus was finally identified through a unique application of molecular cloning techniques by investigators at the Centers for Disease Control, and the Chiron Corporation (1). In a reversal of the usual sequence of events, HCV was identified and defined before its existence was substantiated through tissue culture growth, electron microscopic observation, or serologic detection. Molecular cloning of HCV preceded the use of any of the conventional methods of viral identification and serologic detection then evolved from the blind immunoscreening of millions of clones with serum from a patient who had NANB hepatitis (2). The peptide expressed in a single reactive clone (5-1-1) served as the basis for the first Food and Drug Administration (FDA)-licensed diagnostic test for detection of antibodies to HCV (3).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., and Houghton, M. (1989) Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome. Science 224, 359–362.
Alter, H. J. (1991) Descartes before the horse: I clone, therefore I am: the hepatitis C virus in current perspective. Ann. Intern. Med. 115, 644–649.
Kuo, G., Choo, Q. L., Alter, H. J., et al. (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244, 362–364.
Simmonds, P., Alberti, A., Alter, H. J., et al. (1994) A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19, 1321–1324 (letter).
Miller, R. H. and Purcell, R. H. (1990) Hepatitis C virus shares amino acid sequence similarities with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc. Natl. Acad. Sci. USA 87, 2057–2061.
Ogata, N., Alter, H. J., Miller R. H., and Purcell, R. H. (1991) Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc. Natl. Acad. Sci. USA 88, 3391–3396.
Gretch, D. R. (1997) Diagnostic tests for hepatitis C. Hepatology 26, 43S–47S.
Daman, M., Cuypers, H. T. M., Zaaijer, H. L., Reesink, H. W., Schaasberg, W. P., Gerlich, W. H., Miesters, H. G. M., and Lelie, P. N. (1996) International collaborative study on the second EUROHEP HCV-RNA reference panel. J. Virol. Methods 58, 175–185.
Young, K. K. Y., Resnick, R. M., and Myers, T. W. (1995) Detection of hepatitis C virus RNA by a combined reverse transcription-polymerase chain reaction assay. J. Clin. Microbiol. 31, 882–886.
Zeuzem, S., Ruster, B., and Roth, W. K. (1994) Clinical evaluation of a new poly-merase chain reaction assay (AmplicorTM HCV) for detection of hepatitis C virus. Z. Gastroenterol. 32, 342–347.
Nolte, F. S., Thurmond, C., and Fried, M. W. (1995) Preclinical evaluation of AMPLICOR hepatitis C virus test for detection of hepatitis C virus RNA. J. Clin. Microbiol. 33, 1775–1778.
Bukh, J., Purcell, R. H., and Miller, R. H. (1992) Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 89, 187–191.
Myers, T. W. and Gelfand, D. H. (1991) Reverse transcription and DNA amplification by a thermus thermophilus DNA polymerase. Biochemistry 30, 7661–7666.
Longo, M. C., Berninger, M. S. and Hartley, J. L. (1990) Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene 93, 125–128.
Mahaney, K., Tedeschi, V., Maertens, G., Di Bisceglia, A., Vergalia, J., Hoofnagle, J., and Sallie, R. (1994) Genotypic analysis of hepatitis C virus in American patients. Hepatology 20, 1405–1411.
Lau, J. Y. N., Mizokami, M., Kolberg, J. A., et al. (1995) Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J. Infect. Dis. 171, 218–289.
McHutchison, J. G., Gordon, S., Schiff, E. R., et al. (1998) Interferon alpha-2b alone or in combination of ribavirin as initial treatment for chronic hepatitis C. N. Engl. J. Med. 339, 1485–1499.
Poynard, T., Marcellin, P., Lee, S. S., et al. (1998) Randomised trial of interferon a2b plus ribavirin for 48 weeks or for 24 weeks versus interferon a2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 352, 1426–1432.
Cha, T. A., Beall, E., Irvine, B., et al. (1992) At least five related, but distinct, hepatitis C viral genotypes exist. Proc. Natl. Acad. Sci. USA 89, 7144–7148.
Chan, S. W., McOmish, F., Holmes, E. C., et al. (1992) Analysis of a new hepatitis C virus type and its phyylogenetic relationship to existing variants. J. Gen. Virol. 73, 1131–1141.
Bukh, J., Purcell, R. H., and Miller, R. H. (1993) At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc. Natl. Acad. Sci. USA 90, 8234–8238.
Simmonds, P., Holmes, E. C., Cha, T.-A., et al. (1993) Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J. Gen. Virol. 74, 2391–2399.
Okamoto, H., Sugiyama, Y., Okada, S., et al. (1992) Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J. Gen. Virol. 73, 673–679.
Chayama, K., Tsubota, A., Arase, Y., et al. (1993) Genotypic subtyping of hepatitis C virus. J. Gastroenterol. Hepatol. 8, 150–156.
Nakao, T., Enomoto, N., Tadada, N., Tadada, A., and Date, T., (1991) Typing of hepatitis C virus genomes by restriction fragment length polymorphism. J. Gen. Virol. 72, 2105–2112.
Takada, N., Takase, S., Enomoto, N., Takada, A., and Date, T. (1992) Clinical backgrounds of the patients having different types of hepatitis C virus genomes. J. Hepatol. 14, 35–40.
Stuyver, L., Rossau, R., Wyseur, A., Duhamel, M., Vanderborght, B., Van Heuverswyn, H., and Maertens, G. (1993) Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J. Gen. Virol. 74, 1093–1102.
Marshall, D. J., Heisler, L. M., Lyamichev, V., Murvine, C., Olive, D. M., Ehrlich, G. D., Neri, B. P., and deArruda, M. (1997) Determination of hepatitis C virus genotypes in the United States by cleavase fragment length polymorphism analysis. J. Clin. Microbiol. 35, 3156–3162.
Simmonds, P., Rose, K. A., Graham, S., et al. (1993) Mapping of serotype-specific immunodominant epitopes in the HS-4 region of hepatitis C virus (HCV). Use of type-specific pep tides to serologically differentiate infections with HCV type 1, type 2 and type 3. J. Clin. Microbiol. 31, 1493–1503.
Bhattacherjee, V., Prescott, L. E., Pike, I., et al. (1995) Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6. J. Gen. Virol. 76, 1737–1748.
Andonov, A. and Chaudhary, R. K. (1995) Subtyping of hepatitis C virus isolates by a line probe assay using hybridization. J. Clin. Microbiol. 33, 254–256.
Lau, J. Y. N., Simmonds P., and Urdea, M. S. (1995) Implications of variations of “conserved” regions of hepatitis C virus genome. Lancet 346, 425, 426.
Hadziyannis, E., Larsen, N., Thurmond, C., Mauer, D., and Nolte, F. (1997) Genotyping of hepatitis C virus with direct sequencing: comparison with a line probe assay, in Program and Abstracts of the Annual Meeting of the Association of Molecular Pathology, San Diego, CA.
Nolte, F. S., Thurmond, C., and Mitchell, P. S. (1994) Isolation of hepatitis C virus RNA from serum for reverse transcription-PCR. J. Clin. Microbiol. 32, 519,520.
Hadziyannis, E., Fried, M., and Nolte, F. S. (1995) Evaluation of two methods for quantitation of hepatitis C virus RNA, in Program and Abstracts of the 46th Annual Meeting of the American Association for the Study of Liver Diseases, Chicago, p. 356A.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc.
About this protocol
Cite this protocol
Nolte, F.S. (2001). Detection and Typing of Hepatitis C Virus. In: Killeen, A.A. (eds) Molecular Pathology Protocols. Methods in Molecular Medicine™, vol 49. Humana Press. https://doi.org/10.1385/1-59259-081-0:363
Download citation
DOI: https://doi.org/10.1385/1-59259-081-0:363
Publisher Name: Humana Press
Print ISBN: 978-0-89603-681-9
Online ISBN: 978-1-59259-081-0
eBook Packages: Springer Protocols